TEL
027-62435310
Wuhan Benagen Technology Company Limited (hereinafter referred to as "Benagen") was established in 2012 and is headquartered in high tech Zone
, Wuhan, which is a national high-tech solutions company focusing on the development and application of Nanopore sequencing, second-generation sequencing and biological information analysis technology. The core team has been engaged in high-throughput sequencing, Nanopore sequencing and bioinformatics analysis for many years. The achievements of independent or cooperative research have been published in Nature and Science series journals. More than 72% of the employees have commenced PhD or Master's degree.
We have an independent sequencing platform, which is the first batch of Nanopore PromethION platforms introduced in China. Nanopore DNA sequencing platform is uniquely scalable from pocket-sized formats through to ultra-high throughput devices. This platform has been used in many researches in human, plant, animal, microbiological or environmental genetics, as well as increasingly in applied market applications such as healthcare or food safety.
We are participating and promoting the “1K Medicinal Plants Genome Research Project”, and are building the genome database of medicinal plant.
We have reported the sequencing, de novo assembly and annotation of Chrysanthemum nankingense, which is the world's first large and complex plant genome sequencing by Oxford Nanopore platform.
We have researched and developed the Microbial Detection System based on the Nanopore platform independently, which covers all microbial genomes published.
Furthermore, we are still promoting “10K Microbial Genomes Research Project” and “100K Metagenomics of Human Microbiome Research Project” based on Nanopore platform, and committing to the development of genome sequencing.